| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 208 |
| 1 | PREDNISONE | 184 |
| 2 | METHOTREXATE | 180 |
| 3 | CYCLOPHOSPHAMIDE | 139 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 139 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 139 |
| 6 | MYCOPHENOLATE MOFETIL | 137 |
| 7 | DEXAMETHASONE | 129 |
| 8 | DEXAMETHASONE 1.5 MG | 128 |
| 9 | RITUXIMAB | 123 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CYTARABINE | 80 | 0.0013 |
| 1 | MYCOPHENOLATE MOFETIL | 137 | 0.0010 |
| 2 | TACROLIMUS OINTMENT 0.1% | 112 | 0.0009 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 112 | 0.0009 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 139 | 0.0008 |
| 5 | CYCLOPHOSPHAMIDE | 139 | 0.0008 |
| 6 | TACROLIMUS | 115 | 0.0007 |
| 7 | CYCLOSPORINE | 78 | 0.0007 |
| 8 | RITUXIMAB | 123 | 0.0006 |
| 9 | PREDNISOLONE ORAL SOLUTION | 92 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 452 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 215 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 196 |
| 3 | Alkylating Drug [EPC] | 187 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 186 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 151 |
| 6 | Kinase Inhibitor [EPC] | 125 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 115 |
| 8 | Azole Antifungal [EPC] | 90 |
| 9 | Loop Diuretic [EPC] | 81 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 21 | 0.0036 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 21 | 0.0016 |
| 3 | Cannabinoid [EPC] | 13 | 0.0016 |
| 4 | Lipopeptide Antibacterial [EPC] | 15 | 0.0016 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 6 | 0.0015 |
| 6 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 7 | Provitamin D2 Compound [EPC] | 42 | 0.0014 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |
| 9 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |